Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CMB Collegium Medicum Berlin GmbH is a specialized clinical research organization (CRO) and medical service provider based in Berlin, Germany. Founded and led by Dr. Martina Ulrich, the company focuses on the planning, implementation, and evaluation of clinical trials in the field of dermatology and medical cosmetics. CMB is particularly recognized for its expertise in advanced non-invasive diagnostic imaging technologies, such as Dynamic Optical Coherence Tomography (D-OCT) and Reflectance Confocal Microscopy (RCM). The company serves as a key partner for international pharmaceutical companies, conducting Phase II through IV clinical trials for various skin conditions, including atopic dermatitis and non-melanoma skin cancer. CMB maintains strong academic ties, frequently collaborating with institutions like Charité – Universitätsmedizin Berlin on dermatological research and technology validation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Collegium Medicum Berlin.